source clustersSource Clusters is the single source of information on regional development in the life sciences sector worldwide.

With content providing broad overviews as well as in-depth coverage of business development trends, company activities, life science cluster collaborations, multi-partner scientific projects and its extensive news coverage, Source Clusters presents the latest management, research, technology and regional development information serving the needs of executives in the internationally growing life sciences sector.

Source Clusters is the essential resource for companies, incubators, science parks, clusters and regional development agencies looking to find a new location or attract new business and exploit new opportunities across the life sciences sector.

Optibrium appoints Clare Devlin as financial director

Optibrium Clare Devlin 30.1.19Drug discovery software development specialist Optibrium has appointed Clare Devlin as its financial director. As well as managing all financial aspects of the business, Devlin will be part of the senior team developing business strategy and objectives. She has extensive commercial experience, having held financial director roles at Scintacor, Addviso and Genestack, and specialises in business advice, management and financial accounting, business planning, forecasting and restructuring.

Last year saw Optibrium relocate its Headquarters and R&D facilities to larger premises in Cambridge, UK, with the capacity to accommodate future growth and newly extended offices have allowed the company to invest further in accelerating its R&D pipeline by expanding the team with three additional software engineers. Optibrium launched the latest version of its lead product, StarDrop 6.5, last year and is developing new product features for introduction later this year. The extra office space is set to accommodate these developments, as well as new strategic partnerships and collaborations.

For further information about Optibrium visit www.optibrium.com

Last modified onFriday, 01 March 2019 07:50

Related items

Latest from Tom Mulligan